MoonLake Immunotherapeutics
Hedge Funds Holdings
Last updated:
MoonLake Immunotherapeutics‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 8.77% of the total amount of its stocks outstanding. This makes up a total of 2.57M shares of MoonLake Immunotherapeutics. Compared to the previous quarter, the number fell by -93.18% or -35.17M shares fewer. As for the holding position changes, 28.57% (4) of current hedge fund investors increased the number of shares held, 21.43% (3) of current holders sold a part of the shares held, and 42.86% (6) closed the holdings completely. 5 hedge funds are new holders of MoonLake Immunotherapeutics stock in Q1 2023, it is 35.71% of total holders.
Hedge funds holding MoonLake Immunotherapeutics (Q1 2022 – Q1 2023)
| Q1 2022 | 1 |
|---|---|
| Q2 2022 | 22 |
| Q3 2022 | 23 |
| Q4 2022 | 33 |
| Q1 2023 | 14 |
Hedge funds changes in MoonLake Immunotherapeutics positions (Q1 2022 – Q1 2023)
| Q1 2022 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2022 | 22 | 0 | 0 | 1 | -1 |
| Q3 2022 | 4 | 4 | 8 | 3 | 4 |
| Q4 2022 | 14 | 6 | 7 | 4 | 2 |
| Q1 2023 | 5 | 4 | 3 | 6 | -4 |